围术期SARS-CoV-2感染增加死亡、肺部并发症与血栓栓塞事件:荷兰多中心配对队列研究
该研究纳入161例围术期SARS-CoV-2阳性患者与342例阴性对照,采用倾向性评分配对比较临床结局。配对后阳性组123例与对照196例相比,30天死亡率更高(12% vs 4%;P = .009),死亡风险比为3.4(95%CI 1.5-8.5;P = .005),总体、肺部及血栓栓塞并发症亦更常见(P < .01)。作者认为该结果支持推迟择期手术及部分急诊病例。
要点
- 围术期SARS-CoV-2阳性患者30天死亡率显著高于阴性对照(12% vs 4%)。
- 阳性组死亡风险为对照组的3.4倍(95%CI 1.5-8.5)。
- 总体、肺部及血栓栓塞并发症在阳性患者中更常见(P < .01)。
核心结论
- 围术期确诊SARS-CoV-2感染的患者30天死亡率、肺部并发症及血栓栓塞事件风险升高。
- 该结果为推迟择期手术及部分急诊病例提供了循证依据。
研究设计与样本
- 荷兰多中心匹配队列临床研究,纳入27家医院的连续SARS-CoV-2阳性手术患者与4家医院的阴性对照患者。
- 共纳入161例围术期SARS-CoV-2阳性患者与342例阴性对照患者,行倾向性评分配对比较。
主要发现
- 配对前阳性组与对照组30天总体术后死亡率分别为16%与4%(P = .007)。
- 配对后阳性组123例(中位70岁,四分位间距59-77,男性55%)与对照196例(中位69岁,四分位间距58-75,男性53%)比较。
- 配对后30天死亡率阳性组12% vs 对照组4%(P = .009),比值比3.4(95%CI 1.5-8.5;P = .005)。
- 总体、肺部及血栓栓塞并发症在阳性患者中发生更频繁(P < .01)。
临床怎么用
- 围术期合并SARS-CoV-2感染时应充分评估死亡与肺部、血栓栓塞并发症风险。
- 可据此与患者沟通并考虑推迟择期手术及部分急诊病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A direct comparison of severe acute respiratory syndrome coronavirus 2 positive patients with a severe acute respiratory syndrome coronavirus 2 negative control group undergoing an operative intervention during the current pandemic is lacking, and a reliable estimate of the assumed difference in morbidity and mortality between both patient categories remains unknown. METHODS: We included all consecutive patients with a confirmed pre- or postoperative severe acute respiratory syndrome coronavirus 2 positive status (operated in 27 hospitals) and negative control patients (operated in 4 hospitals) undergoing emergency or elective operations. A propensity score-matched comparison of clinical outcomes was performed between severe acute respiratory syndrome coronavirus 2 positive and negative tested patients (control group). Primary outcome was overall 30-day mortality rate between both groups. Main secondary outcomes were overall, pulmonary, and thromboembolic complications. RESULTS: In total, 161 severe acute respiratory syndrome coronavirus 2 positive and 342 control severe acute respiratory syndrome coronavirus 2 negative patients were included in this study. The 30-day overall postoperative mortality rate was greater in the severe acute respiratory syndrome coronavirus 2 positive cohort compared with the negative control group (16% vs 4% respectively; P = .007). After propensity score matching, the severe acute respiratory syndrome coronavirus 2 positive group consisted of 123 patients (median 70 years of age [interquartile range 59-77] and 55% male) were compared with 196 patients in the matched control group (median 69 years (interquartile range 58-75] and 53% male). The 30-day mortality rate and risk were greater in the severe acute respiratory syndrome coronavirus 2 positive group compared with the matched control group (12% vs 4%; P = .009 and odds ratio 3.4 [95% confidence interval 1.5-8.5]; P = .005, respectively). Overall, pulmonary and thromboembolic complications occurred more often in severe acute respiratory syndrome coronavirus 2 positive patients (P < .01). CONCLUSION: Patients diagnosed with perioperative severe acute respiratory syndrome coronavirus 2 have an increased risk of 30-day mortality, pulmonary complications, and thromboembolic events. These findings serve as an evidence-based argument to postpone elective surgery and selected emergency cases.
引用
- Jonker PKC, van der Plas WY, Steinkamp PJ, et al. Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: A Dutch, multicenter, matched-cohort clinical study. Surgery. 2020. PMID: 33158548. doi:10.1016/j.surg.2020.09.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。